Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)
China flag China · Delayed Price · Currency is CNY
107.60
-2.55 (-2.32%)
Sep 26, 2025, 2:45 PM CST

SHA:688578 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Operating Revenue
4,3553,5582,018790.94530.080.55
Upgrade
Other Revenue
0.040.040.060.060.020.02
Upgrade
4,3553,5582,018791530.090.56
Upgrade
Revenue Growth (YoY)
53.03%76.29%155.14%49.22%94409.97%-10.93%
Upgrade
Cost of Revenue
181.74168.99110.0247.1129.950.16
Upgrade
Gross Profit
4,1733,3891,908743.9500.140.4
Upgrade
Selling, General & Admin
1,9141,5781,052524.11366.44185.12
Upgrade
Research & Development
351.13288.99280.92175.71200.61175.42
Upgrade
Other Operating Expenses
57.5346.8126.65.112.791.64
Upgrade
Operating Expenses
2,3221,9131,359705.26569.95362.16
Upgrade
Operating Income
1,8511,476549.5638.64-69.81-361.76
Upgrade
Interest Expense
-0.11-0.07-0.16-0.33-0.61-1.14
Upgrade
Interest & Investment Income
57.8967.0460.1933.0630.0621.4
Upgrade
Currency Exchange Gain (Loss)
0.561.94.3517.17-3.38-0.35
Upgrade
Other Non Operating Income (Expenses)
0.45-0.45-0.26-1.06-0.43-0.1
Upgrade
EBT Excluding Unusual Items
1,9101,544613.6887.47-44.16-341.96
Upgrade
Gain (Loss) on Sale of Investments
43.6228.8922.6732.3648.138.3
Upgrade
Gain (Loss) on Sale of Assets
0.02-0.01-0.02-1.68-0.57-
Upgrade
Asset Writedown
------0.02
Upgrade
Other Unusual Items
188.3545.6619.897.8514.8823.16
Upgrade
Pretax Income
2,1421,619656.2212618.27-310.52
Upgrade
Income Tax Expense
316.91188.6712.05-4.52--
Upgrade
Net Income
1,8251,430644.17130.5218.27-310.52
Upgrade
Net Income to Common
1,8251,430644.17130.5218.27-310.52
Upgrade
Net Income Growth
67.14%121.97%393.54%614.22%--
Upgrade
Shares Outstanding (Basic)
450450450450457370
Upgrade
Shares Outstanding (Diluted)
450450450450457370
Upgrade
Shares Change (YoY)
0.20%-0.18%0.09%-1.49%23.59%2.30%
Upgrade
EPS (Basic)
4.063.181.430.290.04-0.84
Upgrade
EPS (Diluted)
4.063.181.430.290.04-0.84
Upgrade
EPS Growth
66.79%122.38%393.10%625.00%--
Upgrade
Free Cash Flow
1,6341,296606.77-52.21-162.95-285.2
Upgrade
Free Cash Flow Per Share
3.632.881.35-0.12-0.36-0.77
Upgrade
Dividend Per Share
0.8000.6500.400---
Upgrade
Dividend Growth
23.08%62.50%----
Upgrade
Gross Margin
95.83%95.25%94.55%94.05%94.35%71.17%
Upgrade
Operating Margin
42.50%41.47%27.23%4.88%-13.17%-64498.21%
Upgrade
Profit Margin
41.90%40.19%31.92%16.50%3.45%-55361.45%
Upgrade
Free Cash Flow Margin
37.51%36.42%30.06%-6.60%-30.74%-50847.96%
Upgrade
EBITDA
1,8881,512586.558.8-56-349.9
Upgrade
EBITDA Margin
43.34%42.49%29.06%7.43%-10.56%-
Upgrade
D&A For EBITDA
36.4936.3236.9420.1613.8111.86
Upgrade
EBIT
1,8511,476549.5638.64-69.81-361.76
Upgrade
EBIT Margin
42.50%41.47%27.23%4.88%-13.17%-
Upgrade
Effective Tax Rate
14.80%11.66%1.84%---
Upgrade
Revenue as Reported
4,3553,5582,018791530.090.56
Upgrade
Advertising Expenses
-863.51552.06201.3822.440.47
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.